The SARS-CoV-2 virus causes the Covid-19 disease. Credit: Siemens Healthineers.

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

Follow the latest updates of the outbreak on our timeline.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Siemens Healthineers has launched its molecular Fast Track Diagnostics (FTD) SARS-CoV-2 Assay test kit that detects SARS-CoV-2 virus, which causes coronavirus (Covid-19) disease.

The kits are being shipped within the EU for research use only (RUO) to expedite their availability.

The company is pursuing Emergency Use Assessment and Listing (EUAL) from the World Health Organization (WHO) and emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) for clinical use of the kits.

The commercial launch of the assay is planned in the US and Europe after securing regulatory approval.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Siemens Healthineers Molecular Diagnostics head Sebastian Kronmueller said: “With this molecular diagnostic assay, we want to make a contribution to fighting the current Covid-19 global pandemic by delivering fast and accurate SARS-CoV-2 testing.

“The Siemens Healthineers assay is designed to help researchers positively identify the virus in less than three hours so that healthcare professionals can proceed as quickly as possible with the necessary next steps on their patients’ triage paths.”

Like other FTD Respiratory Disease kits from Siemens Healthineers, the FTD SARS-CoV-2 Assay has been optimised on the Biomerieux EasyMag Extraction System and the Applied Biosystems 7500 Real-time PCR Thermocycler. It uses the same workflow, including PCR profile.

The assay can be run in laboratories simultaneously with FTD Respiratory Pathogens 21.

Siemens Healthineers’ FTD Respiratory Pathogens 21 is a molecular syndromic testing panel that detects 21 different upper respiratory pathogens related to acute respiratory infections.

Acquired by Siemens Healthineers Company at the end of 2017, Fast Track Diagnostics has developed the FTD SARS-CoV-2 Assay.